Publication | Open Access
Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment‐naïve, HIV‐1‐infected patients
17
Citations
0
References
2010
Year
Treatment And PreventionHuman RetrovirusWeek 48Tmc278 Vs EfvHiv InfectionClinical TrialsAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyDrug TherapyHivAntiviral DrugMedicineNovember 2010EpidemiologyEfficacy Results
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK